News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Military champion has Prytime Medical ready for prime time

Prytime Medical Devices Inc. CEO David Spencer said his company is poised to take its flagship technology ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
STBTC expands reach in regenerative medicine  at conference in Beijing
December 6, 2011

SAN ANTONIO, Texas - The South Texas Blood & Tissue Center's (STBTC) global influence and worldwide relationships expanded again this month as the center played a key leadership role in the Fourth Annual Congress of Regenerative Medicine & Stem Cell in Beijing, China.

STBTC President and Chief Operating Officer Mary Beth Fisk chaired a forum at the conference on stem cell and tissue engineering projects in North America and other countries, which included her own discussion of regenerative medicine and synergies in cellular therapy, blood and tissue banking.

"To have a prominent role at a gathering of some of the world's leading stem cell and regenerative medicine scientists and organizations speaks volumes about the leading-edge work being done by the great people working at the South Texas Blood & Tissue Center," Fisk said after returning to San Antonio.  "Based on the cord blood stem cell, marrow and tissue work we've been doing for years, and the recent formation of GenCure, our regenerative medicine unit, STBTC is poised to be a major worldwide player in regenerative medicine."  

Regenerative medicine focuses on replacing or regenerating human cells, tissues or organs. Researchers are optimistic about the potential for regenerative therapies to renew damaged tissues and organs and to prompt the body's self-repair of severely damaged tissues or organs. 

STBTC announced the formation of GenCure in August. GenCure encompasses STBTC's bone marrow donor registration, tissue services, peripheral blood and cord blood cellular therapy programs. This includes research collaborations with the Scripps Research Institute, the National Disease Research Interchange (NDRI), the University of Texas Health Science Center, the University of Illinois, Switzerland-based Lonza Group and Germany-based Cytonet.

The Beijing event gave Fisk the opportunity to forge connections with leading regenerative medicine organizations from around the world. In the coming months, Fisk expects to continue dialogs with many of these organizations about potential partnerships and collaborations.  Event organizers noted that more than 200 participants from more than 30 countries attended the conference.

About the South Texas Blood & Tissue Center
The South Texas Blood & Tissue Center (STBTC) is a not-for profit community blood center specializing in a variety of services. Blood Services provides blood, plasma, platelets and other blood components to 100 hospitals and clinics in 43 South Texas counties. STBTC has seven donor rooms in South Texas and conducts multiple mobile blood drives each week. GenCure includes Tissue Services, the National Marrow Donor Program and the Texas Cord Blood Bank. QualTex Laboratories provides specialized testing for blood and source plasma products.

 

Stay informed. Subscribe to BioMed SA news alerts.